[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Gastritis Treatment Market Growth (Status and Outlook) 2024-2030

May 2024 | 160 pages | ID: G8B52FD16112EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Others possible symptoms include nausea and vomiting, bloating, loss of appetite and heartburn. Complications may include bleeding, stomach ulcers, and stomach tumors.

The global Gastritis Treatment market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

LPI (LP Information)' newest research report, the “Gastritis Treatment Industry Forecast” looks at past sales and reviews total world Gastritis Treatment sales in 2023, providing a comprehensive analysis by region and market sector of projected Gastritis Treatment sales for 2024 through 2030. With Gastritis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastritis Treatment industry.

This Insight Report provides a comprehensive analysis of the global Gastritis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastritis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastritis Treatment market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastritis Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastritis Treatment.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report presents a comprehensive overview, market shares, and growth opportunities of Gastritis Treatment market by product type, application, key players and key regions and countries.

Segmentation by type
  • Acid Suppressants
  • Mucosal Protective Agents
  • Gastric Prokinetic Agents
  • Others
Segmentation by application
  • Acute Gastritis
  • Chronic Gastritis
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Sumitomo Dainippon Pharma
  • Cadila Pharmaceuticals
  • Sanofi
  • Teva
  • Johnson & Johnson
  • Pfizer
  • AstraZeneca
  • Novartis
  • Kyowa Kirin Pharmaceuticals
  • Hanmi Pharm
  • Ani Pharmaceuticals
  • Cipla
  • Yangtze River Pharmaceutical Group
  • Tasly Pharmaceuticals
  • Nanjing LaoshanPharmaceutical
  • CR Pharmaceutical
  • Shanghai Pharmaceuticals
  • Chongqing Juqinuomei Pharmaceutical
  • Zhejiang Jingwei Pharmaceutical
  • Tianjin Lisheng Pharmaceutical
  • Aimin Pharmaceutical
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Gastritis Treatment Market Size 2019-2030
  2.1.2 Gastritis Treatment Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Gastritis Treatment Segment by Type
  2.2.1 Acid Suppressants
  2.2.2 Mucosal Protective Agents
  2.2.3 Gastric Prokinetic Agents
  2.2.4 Others
2.3 Gastritis Treatment Market Size by Type
  2.3.1 Gastritis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global Gastritis Treatment Market Size Market Share by Type (2019-2024)
2.4 Gastritis Treatment Segment by Application
  2.4.1 Acute Gastritis
  2.4.2 Chronic Gastritis
2.5 Gastritis Treatment Market Size by Application
  2.5.1 Gastritis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global Gastritis Treatment Market Size Market Share by Application (2019-2024)

3 GASTRITIS TREATMENT MARKET SIZE BY PLAYER

3.1 Gastritis Treatment Market Size Market Share by Players
  3.1.1 Global Gastritis Treatment Revenue by Players (2019-2024)
  3.1.2 Global Gastritis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Gastritis Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 GASTRITIS TREATMENT BY REGIONS

4.1 Gastritis Treatment Market Size by Regions (2019-2024)
4.2 Americas Gastritis Treatment Market Size Growth (2019-2024)
4.3 APAC Gastritis Treatment Market Size Growth (2019-2024)
4.4 Europe Gastritis Treatment Market Size Growth (2019-2024)
4.5 Middle East & Africa Gastritis Treatment Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas Gastritis Treatment Market Size by Country (2019-2024)
5.2 Americas Gastritis Treatment Market Size by Type (2019-2024)
5.3 Americas Gastritis Treatment Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Gastritis Treatment Market Size by Region (2019-2024)
6.2 APAC Gastritis Treatment Market Size by Type (2019-2024)
6.3 APAC Gastritis Treatment Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Gastritis Treatment by Country (2019-2024)
7.2 Europe Gastritis Treatment Market Size by Type (2019-2024)
7.3 Europe Gastritis Treatment Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Gastritis Treatment by Region (2019-2024)
8.2 Middle East & Africa Gastritis Treatment Market Size by Type (2019-2024)
8.3 Middle East & Africa Gastritis Treatment Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL GASTRITIS TREATMENT MARKET FORECAST

10.1 Global Gastritis Treatment Forecast by Regions (2025-2030)
  10.1.1 Global Gastritis Treatment Forecast by Regions (2025-2030)
  10.1.2 Americas Gastritis Treatment Forecast
  10.1.3 APAC Gastritis Treatment Forecast
  10.1.4 Europe Gastritis Treatment Forecast
  10.1.5 Middle East & Africa Gastritis Treatment Forecast
10.2 Americas Gastritis Treatment Forecast by Country (2025-2030)
  10.2.1 United States Gastritis Treatment Market Forecast
  10.2.2 Canada Gastritis Treatment Market Forecast
  10.2.3 Mexico Gastritis Treatment Market Forecast
  10.2.4 Brazil Gastritis Treatment Market Forecast
10.3 APAC Gastritis Treatment Forecast by Region (2025-2030)
  10.3.1 China Gastritis Treatment Market Forecast
  10.3.2 Japan Gastritis Treatment Market Forecast
  10.3.3 Korea Gastritis Treatment Market Forecast
  10.3.4 Southeast Asia Gastritis Treatment Market Forecast
  10.3.5 India Gastritis Treatment Market Forecast
  10.3.6 Australia Gastritis Treatment Market Forecast
10.4 Europe Gastritis Treatment Forecast by Country (2025-2030)
  10.4.1 Germany Gastritis Treatment Market Forecast
  10.4.2 France Gastritis Treatment Market Forecast
  10.4.3 UK Gastritis Treatment Market Forecast
  10.4.4 Italy Gastritis Treatment Market Forecast
  10.4.5 Russia Gastritis Treatment Market Forecast
10.5 Middle East & Africa Gastritis Treatment Forecast by Region (2025-2030)
  10.5.1 Egypt Gastritis Treatment Market Forecast
  10.5.2 South Africa Gastritis Treatment Market Forecast
  10.5.3 Israel Gastritis Treatment Market Forecast
  10.5.4 Turkey Gastritis Treatment Market Forecast
  10.5.5 GCC Countries Gastritis Treatment Market Forecast
10.6 Global Gastritis Treatment Forecast by Type (2025-2030)
10.7 Global Gastritis Treatment Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Sumitomo Dainippon Pharma
  11.1.1 Sumitomo Dainippon Pharma Company Information
  11.1.2 Sumitomo Dainippon Pharma Gastritis Treatment Product Offered
  11.1.3 Sumitomo Dainippon Pharma Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Sumitomo Dainippon Pharma Main Business Overview
  11.1.5 Sumitomo Dainippon Pharma Latest Developments
11.2 Cadila Pharmaceuticals
  11.2.1 Cadila Pharmaceuticals Company Information
  11.2.2 Cadila Pharmaceuticals Gastritis Treatment Product Offered
  11.2.3 Cadila Pharmaceuticals Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 Cadila Pharmaceuticals Main Business Overview
  11.2.5 Cadila Pharmaceuticals Latest Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Gastritis Treatment Product Offered
  11.3.3 Sanofi Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi Latest Developments
11.4 Teva
  11.4.1 Teva Company Information
  11.4.2 Teva Gastritis Treatment Product Offered
  11.4.3 Teva Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Teva Main Business Overview
  11.4.5 Teva Latest Developments
11.5 Johnson & Johnson
  11.5.1 Johnson & Johnson Company Information
  11.5.2 Johnson & Johnson Gastritis Treatment Product Offered
  11.5.3 Johnson & Johnson Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 Johnson & Johnson Main Business Overview
  11.5.5 Johnson & Johnson Latest Developments
11.6 Pfizer
  11.6.1 Pfizer Company Information
  11.6.2 Pfizer Gastritis Treatment Product Offered
  11.6.3 Pfizer Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 Pfizer Main Business Overview
  11.6.5 Pfizer Latest Developments
11.7 AstraZeneca
  11.7.1 AstraZeneca Company Information
  11.7.2 AstraZeneca Gastritis Treatment Product Offered
  11.7.3 AstraZeneca Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 AstraZeneca Main Business Overview
  11.7.5 AstraZeneca Latest Developments
11.8 Novartis
  11.8.1 Novartis Company Information
  11.8.2 Novartis Gastritis Treatment Product Offered
  11.8.3 Novartis Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 Novartis Main Business Overview
  11.8.5 Novartis Latest Developments
11.9 Kyowa Kirin Pharmaceuticals
  11.9.1 Kyowa Kirin Pharmaceuticals Company Information
  11.9.2 Kyowa Kirin Pharmaceuticals Gastritis Treatment Product Offered
  11.9.3 Kyowa Kirin Pharmaceuticals Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Kyowa Kirin Pharmaceuticals Main Business Overview
  11.9.5 Kyowa Kirin Pharmaceuticals Latest Developments
11.10 Hanmi Pharm
  11.10.1 Hanmi Pharm Company Information
  11.10.2 Hanmi Pharm Gastritis Treatment Product Offered
  11.10.3 Hanmi Pharm Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Hanmi Pharm Main Business Overview
  11.10.5 Hanmi Pharm Latest Developments
11.11 Ani Pharmaceuticals
  11.11.1 Ani Pharmaceuticals Company Information
  11.11.2 Ani Pharmaceuticals Gastritis Treatment Product Offered
  11.11.3 Ani Pharmaceuticals Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Ani Pharmaceuticals Main Business Overview
  11.11.5 Ani Pharmaceuticals Latest Developments
11.12 Cipla
  11.12.1 Cipla Company Information
  11.12.2 Cipla Gastritis Treatment Product Offered
  11.12.3 Cipla Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.12.4 Cipla Main Business Overview
  11.12.5 Cipla Latest Developments
11.13 Yangtze River Pharmaceutical Group
  11.13.1 Yangtze River Pharmaceutical Group Company Information
  11.13.2 Yangtze River Pharmaceutical Group Gastritis Treatment Product Offered
  11.13.3 Yangtze River Pharmaceutical Group Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.13.4 Yangtze River Pharmaceutical Group Main Business Overview
  11.13.5 Yangtze River Pharmaceutical Group Latest Developments
11.14 Tasly Pharmaceuticals
  11.14.1 Tasly Pharmaceuticals Company Information
  11.14.2 Tasly Pharmaceuticals Gastritis Treatment Product Offered
  11.14.3 Tasly Pharmaceuticals Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.14.4 Tasly Pharmaceuticals Main Business Overview
  11.14.5 Tasly Pharmaceuticals Latest Developments
11.15 Nanjing LaoshanPharmaceutical
  11.15.1 Nanjing LaoshanPharmaceutical Company Information
  11.15.2 Nanjing LaoshanPharmaceutical Gastritis Treatment Product Offered
  11.15.3 Nanjing LaoshanPharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.15.4 Nanjing LaoshanPharmaceutical Main Business Overview
  11.15.5 Nanjing LaoshanPharmaceutical Latest Developments
11.16 CR Pharmaceutical
  11.16.1 CR Pharmaceutical Company Information
  11.16.2 CR Pharmaceutical Gastritis Treatment Product Offered
  11.16.3 CR Pharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.16.4 CR Pharmaceutical Main Business Overview
  11.16.5 CR Pharmaceutical Latest Developments
11.17 Shanghai Pharmaceuticals
  11.17.1 Shanghai Pharmaceuticals Company Information
  11.17.2 Shanghai Pharmaceuticals Gastritis Treatment Product Offered
  11.17.3 Shanghai Pharmaceuticals Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.17.4 Shanghai Pharmaceuticals Main Business Overview
  11.17.5 Shanghai Pharmaceuticals Latest Developments
11.18 Chongqing Juqinuomei Pharmaceutical
  11.18.1 Chongqing Juqinuomei Pharmaceutical Company Information
  11.18.2 Chongqing Juqinuomei Pharmaceutical Gastritis Treatment Product Offered
  11.18.3 Chongqing Juqinuomei Pharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.18.4 Chongqing Juqinuomei Pharmaceutical Main Business Overview
  11.18.5 Chongqing Juqinuomei Pharmaceutical Latest Developments
11.19 Zhejiang Jingwei Pharmaceutical
  11.19.1 Zhejiang Jingwei Pharmaceutical Company Information
  11.19.2 Zhejiang Jingwei Pharmaceutical Gastritis Treatment Product Offered
  11.19.3 Zhejiang Jingwei Pharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.19.4 Zhejiang Jingwei Pharmaceutical Main Business Overview
  11.19.5 Zhejiang Jingwei Pharmaceutical Latest Developments
11.20 Tianjin Lisheng Pharmaceutical
  11.20.1 Tianjin Lisheng Pharmaceutical Company Information
  11.20.2 Tianjin Lisheng Pharmaceutical Gastritis Treatment Product Offered
  11.20.3 Tianjin Lisheng Pharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.20.4 Tianjin Lisheng Pharmaceutical Main Business Overview
  11.20.5 Tianjin Lisheng Pharmaceutical Latest Developments
11.21 Aimin Pharmaceutical
  11.21.1 Aimin Pharmaceutical Company Information
  11.21.2 Aimin Pharmaceutical Gastritis Treatment Product Offered
  11.21.3 Aimin Pharmaceutical Gastritis Treatment Revenue, Gross Margin and Market Share (2019-2024)
  11.21.4 Aimin Pharmaceutical Main Business Overview
  11.21.5 Aimin Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Gastritis Treatment Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Acid Suppressants
Table 3. Major Players of Mucosal Protective Agents
Table 4. Major Players of Gastric Prokinetic Agents
Table 5. Major Players of Others
Table 6. Gastritis Treatment Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global Gastritis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global Gastritis Treatment Market Size Market Share by Type (2019-2024)
Table 9. Gastritis Treatment Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global Gastritis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global Gastritis Treatment Market Size Market Share by Application (2019-2024)
Table 12. Global Gastritis Treatment Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global Gastritis Treatment Revenue Market Share by Player (2019-2024)
Table 14. Gastritis Treatment Key Players Head office and Products Offered
Table 15. Gastritis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Gastritis Treatment Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global Gastritis Treatment Market Size Market Share by Regions (2019-2024)
Table 20. Global Gastritis Treatment Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Gastritis Treatment Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Gastritis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas Gastritis Treatment Market Size Market Share by Country (2019-2024)
Table 24. Americas Gastritis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas Gastritis Treatment Market Size Market Share by Type (2019-2024)
Table 26. Americas Gastritis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas Gastritis Treatment Market Size Market Share by Application (2019-2024)
Table 28. APAC Gastritis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC Gastritis Treatment Market Size Market Share by Region (2019-2024)
Table 30. APAC Gastritis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC Gastritis Treatment Market Size Market Share by Type (2019-2024)
Table 32. APAC Gastritis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC Gastritis Treatment Market Size Market Share by Application (2019-2024)
Table 34. Europe Gastritis Treatment Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe Gastritis Treatment Market Size Market Share by Country (2019-2024)
Table 36. Europe Gastritis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe Gastritis Treatment Market Size Market Share by Type (2019-2024)
Table 38. Europe Gastritis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe Gastritis Treatment Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa Gastritis Treatment Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Gastritis Treatment Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa Gastritis Treatment Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Gastritis Treatment Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa Gastritis Treatment Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa Gastritis Treatment Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of Gastritis Treatment
Table 47. Key Market Challenges & Risks of Gastritis Treatment
Table 48. Key Industry Trends of Gastritis Treatment
Table 49. Global Gastritis Treatment Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global Gastritis Treatment Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global Gastritis Treatment Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global Gastritis Treatment Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Sumitomo Dainippon Pharma Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 54. Sumitomo Dainippon Pharma Gastritis Treatment Product Offered
Table 55. Sumitomo Dainippon Pharma Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Sumitomo Dainippon Pharma Main Business
Table 57. Sumitomo Dainippon Pharma Latest Developments
Table 58. Cadila Pharmaceuticals Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 59. Cadila Pharmaceuticals Gastritis Treatment Product Offered
Table 60. Cadila Pharmaceuticals Main Business
Table 61. Cadila Pharmaceuticals Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. Cadila Pharmaceuticals Latest Developments
Table 63. Sanofi Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 64. Sanofi Gastritis Treatment Product Offered
Table 65. Sanofi Main Business
Table 66. Sanofi Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Sanofi Latest Developments
Table 68. Teva Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 69. Teva Gastritis Treatment Product Offered
Table 70. Teva Main Business
Table 71. Teva Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Teva Latest Developments
Table 73. Johnson & Johnson Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 74. Johnson & Johnson Gastritis Treatment Product Offered
Table 75. Johnson & Johnson Main Business
Table 76. Johnson & Johnson Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Johnson & Johnson Latest Developments
Table 78. Pfizer Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 79. Pfizer Gastritis Treatment Product Offered
Table 80. Pfizer Main Business
Table 81. Pfizer Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 82. Pfizer Latest Developments
Table 83. AstraZeneca Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 84. AstraZeneca Gastritis Treatment Product Offered
Table 85. AstraZeneca Main Business
Table 86. AstraZeneca Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 87. AstraZeneca Latest Developments
Table 88. Novartis Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 89. Novartis Gastritis Treatment Product Offered
Table 90. Novartis Main Business
Table 91. Novartis Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 92. Novartis Latest Developments
Table 93. Kyowa Kirin Pharmaceuticals Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 94. Kyowa Kirin Pharmaceuticals Gastritis Treatment Product Offered
Table 95. Kyowa Kirin Pharmaceuticals Main Business
Table 96. Kyowa Kirin Pharmaceuticals Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 97. Kyowa Kirin Pharmaceuticals Latest Developments
Table 98. Hanmi Pharm Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 99. Hanmi Pharm Gastritis Treatment Product Offered
Table 100. Hanmi Pharm Main Business
Table 101. Hanmi Pharm Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 102. Hanmi Pharm Latest Developments
Table 103. Ani Pharmaceuticals Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 104. Ani Pharmaceuticals Gastritis Treatment Product Offered
Table 105. Ani Pharmaceuticals Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 106. Ani Pharmaceuticals Main Business
Table 107. Ani Pharmaceuticals Latest Developments
Table 108. Cipla Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 109. Cipla Gastritis Treatment Product Offered
Table 110. Cipla Main Business
Table 111. Cipla Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 112. Cipla Latest Developments
Table 113. Yangtze River Pharmaceutical Group Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 114. Yangtze River Pharmaceutical Group Gastritis Treatment Product Offered
Table 115. Yangtze River Pharmaceutical Group Main Business
Table 116. Yangtze River Pharmaceutical Group Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 117. Yangtze River Pharmaceutical Group Latest Developments
Table 118. Tasly Pharmaceuticals Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 119. Tasly Pharmaceuticals Gastritis Treatment Product Offered
Table 120. Tasly Pharmaceuticals Main Business
Table 121. Tasly Pharmaceuticals Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 122. Tasly Pharmaceuticals Latest Developments
Table 123. Nanjing LaoshanPharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 124. Nanjing LaoshanPharmaceutical Gastritis Treatment Product Offered
Table 125. Nanjing LaoshanPharmaceutical Main Business
Table 126. Nanjing LaoshanPharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 127. Nanjing LaoshanPharmaceutical Latest Developments
Table 128. CR Pharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 129. CR Pharmaceutical Gastritis Treatment Product Offered
Table 130. CR Pharmaceutical Main Business
Table 131. CR Pharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 132. CR Pharmaceutical Latest Developments
Table 133. Shanghai Pharmaceuticals Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 134. Shanghai Pharmaceuticals Gastritis Treatment Product Offered
Table 135. Shanghai Pharmaceuticals Main Business
Table 136. Shanghai Pharmaceuticals Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 137. Shanghai Pharmaceuticals Latest Developments
Table 138. Chongqing Juqinuomei Pharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 139. Chongqing Juqinuomei Pharmaceutical Gastritis Treatment Product Offered
Table 140. Chongqing Juqinuomei Pharmaceutical Main Business
Table 141. Chongqing Juqinuomei Pharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 142. Chongqing Juqinuomei Pharmaceutical Latest Developments
Table 143. Zhejiang Jingwei Pharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 144. Zhejiang Jingwei Pharmaceutical Gastritis Treatment Product Offered
Table 145. Zhejiang Jingwei Pharmaceutical Main Business
Table 146. Zhejiang Jingwei Pharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 147. Zhejiang Jingwei Pharmaceutical Latest Developments
Table 148. Tianjin Lisheng Pharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 149. Tianjin Lisheng Pharmaceutical Gastritis Treatment Product Offered
Table 150. Tianjin Lisheng Pharmaceutical Main Business
Table 151. Tianjin Lisheng Pharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 152. Tianjin Lisheng Pharmaceutical Latest Developments
Table 153. Aimin Pharmaceutical Details, Company Type, Gastritis Treatment Area Served and Its Competitors
Table 154. Aimin Pharmaceutical Gastritis Treatment Product Offered
Table 155. Aimin Pharmaceutical Gastritis Treatment Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 156. Aimin Pharmaceutical Main Business
Table 157. Aimin Pharmaceutical Latest Developments

LIST OF FIGURES

Figure 1. Gastritis Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastritis Treatment Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Gastritis Treatment Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Gastritis Treatment Sales Market Share by Country/Region (2023)
Figure 8. Gastritis Treatment Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Gastritis Treatment Market Size Market Share by Type in 2023
Figure 10. Gastritis Treatment in Acute Gastritis
Figure 11. Global Gastritis Treatment Market: Acute Gastritis (2019-2024) & ($ Millions)
Figure 12. Gastritis Treatment in Chronic Gastritis
Figure 13. Global Gastritis Treatment Market: Chronic Gastritis (2019-2024) & ($ Millions)
Figure 14. Global Gastritis Treatment Market Size Market Share by Application in 2023
Figure 15. Global Gastritis Treatment Revenue Market Share by Player in 2023
Figure 16. Global Gastritis Treatment Market Size Market Share by Regions (2019-2024)
Figure 17. Americas Gastritis Treatment Market Size 2019-2024 ($ Millions)
Figure 18. APAC Gastritis Treatment Market Size 2019-2024 ($ Millions)
Figure 19. Europe Gastritis Treatment Market Size 2019-2024 ($ Millions)
Figure 20. Middle East & Africa Gastritis Treatment Market Size 2019-2024 ($ Millions)
Figure 21. Americas Gastritis Treatment Value Market Share by Country in 2023
Figure 22. United States Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 23. Canada Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 24. Mexico Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 25. Brazil Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 26. APAC Gastritis Treatment Market Size Market Share by Region in 2023
Figure 27. APAC Gastritis Treatment Market Size Market Share by Type in 2023
Figure 28. APAC Gastritis Treatment Market Size Market Share by Application in 2023
Figure 29. China Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 30. Japan Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 31. Korea Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 32. Southeast Asia Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 33. India Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 34. Australia Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 35. Europe Gastritis Treatment Market Size Market Share by Country in 2023
Figure 36. Europe Gastritis Treatment Market Size Market Share by Type (2019-2024)
Figure 37. Europe Gastritis Treatment Market Size Market Share by Application (2019-2024)
Figure 38. Germany Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 39. France Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 40. UK Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 41. Italy Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 42. Russia Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 43. Middle East & Africa Gastritis Treatment Market Size Market Share by Region (2019-2024)
Figure 44. Middle East & Africa Gastritis Treatment Market Size Market Share by Type (2019-2024)
Figure 45. Middle East & Africa Gastritis Treatment Market Size Market Share by Application (2019-2024)
Figure 46. Egypt Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 47. South Africa Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 48. Israel Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 49. Turkey Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 50. GCC Country Gastritis Treatment Market Size Growth 2019-2024 ($ Millions)
Figure 51. Americas Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 52. APAC Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 53. Europe Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 54. Middle East & Africa Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 55. United States Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 56. Canada Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 57. Mexico Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 58. Brazil Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 59. China Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 60. Japan Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 61. Korea Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 62. Southeast Asia Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 63. India Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 64. Australia Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 65. Germany Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 66. France Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 67. UK Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 68. Italy Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 69. Russia Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 70. Spain Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 71. Egypt Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 72. South Africa Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 73. Israel Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 74. Turkey Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 75. GCC Countries Gastritis Treatment Market Size 2025-2030 ($ Millions)
Figure 76. Global Gastritis Treatment Market Size Market Share Forecast by Type (2025-2030)
Figure 77. Global Gastritis Treatment Market Size Market Share Forecast by Application (2025-2030)


More Publications